CFM
RLYB icon

Catalyst Funds Management’s Rallybio RLYB Stock Holding History

Catalyst Funds Management’s Portfolio RLYB Stock Details RLYB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-975
Closed -$9.13K – 1074
2024
Q3 		$9.13K Hold
975
– – ﹤0.01% 1199
2024
Q2 		$10.5K Buy
+975
New +$13.2K ﹤0.01% 907

Other funds holding RLYB

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $76.1M AUM 638.59% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

Catalyst Funds Management's RLYB Position: Q4 2024 in Review

Catalyst Funds Management sold out of Rallybio (RLYB) in Q4 2024, closing a stake of 975 shares — an estimated $9.13K sold.

Catalyst Funds Management first reported a position in RLYB in Q2 2024 and held it in 2 quarters. The position peaked at $10.5K in Q2 2024. 49 funds tracked by Wall St. Rank hold RLYB as of Q4 2024.

  • Catalyst Funds Management reported no remaining Rallybio position as of Q4 2024 after selling out during the quarter.
  • Catalyst Funds Management sold 975 Rallybio shares in Q4 2024, an estimated $9.13K.
  • Catalyst Funds Management first reported a position in Rallybio in Q2 2024 and held it in 2 quarters.
  • Catalyst Funds Management's Rallybio position peaked at $10.5K in Q2 2024.
  • 49 funds tracked by Wall St. Rank held Rallybio as of Q4 2024.

Based on Catalyst Funds Management's 13F filing for Q4 2024, filed 10 Feb 2025.